跳转至内容
Merck
  • Itraconazole treatment of nonmeningeal coccidioidomycosis in children: two case reports and review of the literature.

Itraconazole treatment of nonmeningeal coccidioidomycosis in children: two case reports and review of the literature.

The Pediatric infectious disease journal (2009-11-04)
James D Homans, LaShonda Spencer
摘要

Coccidioides immitis causes a wide range of disease in humans. Fluconazole and itraconazole are effective treatments. Clinical evidence suggests that itraconazole is equivalent or superior to fluconazole in treating osteoarticular infections in rates of cure and recurrence. We report 2 cases of coccidioidomycosis involving bone in children successfully treated with itraconazole oral solution. Itraconazole oral solution is effective in treating nonmeningeal coccidioidomycosis in children, particularly skeletal disease, and infections that are refractory to fluconazole.

材料
货号
品牌
产品描述

Sigma-Aldrich
伊曲康唑, ≥98% (HPLC)
Supelco
Itraconazole solution, 2.0 mg/mL (Methanol with 1% 1M HCl), ampule of 1 mL, certified reference material, Cerilliant®
伊曲康唑, European Pharmacopoeia (EP) Reference Standard
伊曲康唑, European Pharmacopoeia (EP) Reference Standard